Notes from the Field: Six Cases of Acute Flaccid Myelitis in Children — Minnesota, 2018
Weekly / April 19, 2019 / 68(15);356–358
Heidi Moline, MD1; Anupama Kalaskar, MD2; William F. Pomputius III, MD2; Adriana Lopez, MHS3; Janell Routh, MD3; Cynthia Kenyon, MPH4; Jayne Griffith, MA, MPH4 (View author affiliations)View suggested citation
Views equals page views plus PDF downloads
- pdf icon [PDF]
During September 14–October 1, 2018, the Minnesota Department of Health (MDH) was notified of six children hospitalized in the Minneapolis-St. Paul region with symptoms consistent with acute flaccid myelitis (AFM). A confirmed case of AFM is defined as acute onset of flaccid limb weakness with magnetic resonance image indicating spinal cord lesions largely restricted to gray matter and spanning one or more vertebral segments (1). All six cases were confirmed by CDC. After a cluster of three cases occurred in 2014, an average of fewer than one AFM case per year had been reported to MDH.
Among the six patients, the median patient age was 6.0 years (range = 1.3–9.2 years). All children resided in different Minnesota counties, and all experienced fever and upper respiratory signs and symptoms (e.g., rhinorrhea and cough) beginning a median of 8 days (range = 5–11 days) before weakness onset; none had a history of being immunocompromised. In addition, four patients experienced neck pain or headache, and two experienced diarrhea before weakness onset. Four patients had marked weakness of proximal muscle groups in one arm, although distal motor function was largely preserved. The other two patients initially had weakness in one leg, which became bilateral and rapidly ascended during hospitalization; both of these patients required endotracheal intubation and mechanical ventilation. In all six patients, limb weakness was first noted after waking in the morning. No epidemiologic links among patients were identified.
All six patients were hospitalized. Three patients were discharged home, and two were discharged to inpatient rehabilitation facilities. One patient remains hospitalized with complete paralysis of all voluntary muscles, including the diaphragm, at the time of this report. All discharged patients had residual weakness at time of discharge; among these patients, the median duration of hospitalization was 8 days (range = 1–14 days).
Magnetic resonance imaging (MRI) indicated spinal cord gray matter involvement in all six patients, largely in the anterior horns. The extent of gray matter involvement did not always correlate with deficits seen on physical exam; in three patients with only single limb weakness, multisegment gray matter involvement was apparent. Among all patients, three had anterior nerve root and facial nerve enhancement, and two had basilar and brainstem involvement. Three patients had normal MRI findings early in the illness course, but demonstrated extensive gray matter involvement on a subsequent MRI.
Cerebrospinal fluid (CSF) was collected in five patients, with pleocytosis (white blood cell count >5 cells/mm3) present in two patients (Table). One CSF specimen (patient B) was positive for enterovirus (not typed) by reverse transcription–polymerase chain reaction (RT-PCR) at a commercial reference laboratory. Serum, CSF, stool, and nasopharyngeal specimens from five patients were tested at CDC. One nasopharyngeal swab (patient D) was positive for enterovirus-D68 (EV-D68) by real-time RT-PCR. One nasal wash specimen from patient B was positive for EV-D68 and a second specimen for EV-D68 and parechovirus A6 by real-time RT-PCR; CSF from this patient also was positive for EV-D68. The remaining specimens were negative, including those from three patients who had no positive specimens. All stool specimens were negative for poliovirus.
Five of six patients received some form of immunomodulatory treatment (Table). One patient was treated with steroids and plasmapheresis followed by intravenous immune globulin (IVIG), one with steroids followed by IVIG, three with only IVIG, and one with supportive care only.
This AFM cluster, the largest identified in Minnesota, occurred during a period of increased reporting of AFM nationally and is consistent with the epidemiologic and clinical characteristics of previously described AFM clusters (2–6). Despite report of upper respiratory tract signs and symptoms in all patients, testing for viruses that commonly cause upper respiratory tract infections was positive from nonsterile specimens in only two cases. EV-D68 in the CSF of patient B is considered the cause of AFM in this patient. Detection of a pathogen in the CSF might be related to the severity and prolonged nature of illness in this patient; however, host or other factors contributing to illness severity are unknown.
AFM is a rare but serious cause of sudden onset limb weakness, especially in children, and should be considered in the differential diagnosis. Diagnosis and care of patients with AFM includes early collection of specimens, including CSF, for laboratory testing, MRI scans, and consultation with neurology and infectious disease experts. Potential cases should be reported to public health departments in a timely manner. Public health classification of AFM cases involves expert review of clinical and imaging findings; however, it is important that clinical care not be delayed pending case classification.
Corresponding author: Heidi Moline, firstname.lastname@example.org.
1Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, University of Minnesota Medical School, Minneapolis, Minnesota; 2Division of Infectious Disease, Children’s Hospitals and Clinics of Minnesota, Minneapolis, Minnesota; 3National Center for Immunization and Respiratory Diseases, CDC; 4Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health.
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- CDC. Acute flaccid myelitis (AFM) 2018 case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://wwwn.cdc.gov/nndss/conditions/acute-flaccid-myelitis/case-definition/2018/
- Messacar K, Schreiner TL, Van Haren K, et al. Acute flaccid myelitis: a clinical review of US cases 2012–2015. Ann Neurol 2016;80:326–38. CrossRefexternal icon PubMedexternal icon
- Maloney JA, Mirsky DM, Messacar K, Dominguez SR, Schreiner T, Stence NV. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. AJNR Am J Neuroradiol 2015;36:245–50. CrossRefexternal icon PubMedexternal icon
- Iverson SA, Ostdiek S, Prasai S, et al. ; AFM Investigation Team. Notes from the field: cluster of acute flaccid myelitis in five pediatric patients—Maricopa County, Arizona, 2016. MMWR Morb Mortal Wkly Rep 2017;66:758–60. CrossRefexternal icon PubMedexternal icon
- Bonwitt J, Poel A, DeBolt C, et al. Acute flaccid myelitis among children—Washington, September–November 2016. MMWR Morb Mortal Wkly Rep 2017;66:826–9. CrossRefexternal icon PubMedexternal icon
- Sejvar JJ, Lopez AS, Cortese MM, et al. Acute flaccid myelitis in the United States, August–December 2014: results of nationwide surveillance. Clin Infect Dis 2016;63:737–45. CrossRefexternal icon PubMedexternal icon
Suggested citation for this article: Moline H, Kalaskar A, Pomputius WF III, et al. Notes from the Field: Six Cases of Acute Flaccid Myelitis in Children — Minnesota, 2018. MMWR Morb Mortal Wkly Rep 2019;68:356–358. DOI: http://dx.doi.org/10.15585/mmwr.mm6815a4external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to email@example.com.